StockData
Immuneering Corp logo

Immuneering Corp (IMRX) stock

IMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30
$3.46−0.06 (-1.70%)

Close on Nov 17, 2026Market cap $224.08MP/E –Yield –

Immuneering market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immuneering's market cap was $221.57M on Nov 11, 2026, against $272.40M a year earlier. Over the last 5 years it ranged from $32.63M to $347.78M, with a median of $164.65M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$221.57M-5.3%
2025Dec 31, 2025$233.99M+260.1%
2024Dec 31, 2024$64.98M-68.1%
2023Dec 29, 2023$203.53M+59.5%
2022Dec 30, 2022$127.62M-4.7%
2021Dec 31, 2021$133.97M–

More Immuneering figures

See a number that looks wrong?